|
ATP5A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.19649862134952E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.99109642504436E-11 |
| Normal-vs-Stage2 |
6.217800E-01 |
| Normal-vs-Stage3 |
3.23119309086906E-12 |
| Normal-vs-Stage4 |
1.9710899579195E-12 |
| Stage1-vs-Stage2 |
1.422780E-03 |
| Stage1-vs-Stage3 |
1.295980E-01 |
| Stage1-vs-Stage4 |
6.700800E-03 |
| Stage2-vs-Stage3 |
2.594200E-04 |
| Stage2-vs-Stage4 |
2.07479999999594E-05 |
| Stage3-vs-Stage4 |
1.233150E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99062988315291E-12 |
| Normal-vs-AfricanAmerican |
4.1045999999989E-06 |
| Normal-vs-Asian |
4.04530000053249E-07 |
| Caucasian-vs-AfricanAmerican |
7.600800E-01 |
| Caucasian-vs-Asian |
9.476400E-01 |
| AfricanAmerican-vs-Asian |
7.477000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.27589999676658E-08 |
| Normal-vs-Female |
1.56269996942626E-10 |
| Male-vs-Female |
6.354200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.9112935940343E-12 |
| Normal-vs-Age(41-60Yrs) |
1.09910003320834E-09 |
| Normal-vs-Age(61-80Yrs) |
4.118000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.009350E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.265200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.001500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.026400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.336410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.196800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.149400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.737800E-03 |
| Classical-VS-Follicular |
2.02149999999346E-05 |
| Classical-VS-Other |
4.704600E-01 |
| Classical-VS-Normal |
1.67155178587564E-12 |
| Tall-VS-Follicular |
3.20290000077605E-08 |
| Tall-VS-Other |
8.443000E-01 |
| Tall-VS-Normal |
1.64535052249448E-12 |
| Follicular-VS-Other |
8.288400E-02 |
| Follicular-VS-Normal |
5.459000E-01 |
| Other-VS-Normal |
3.139800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.43600000019384E-07 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
1.05620001633611E-09 |
|
|
